InformasjonVed hyperhidrose er nervene som skal trigge svettekjertlene overaktive.
Svette hender og føtter
Svette hender og føtter skyldes vanligvis ikke en sykdom. Problemet debuterer ofte i barndommen. Ofte er det en overhyppighet i familien. Det synes å være en arvelig komponent.
Sist oppdatert:
13. apr. 2022
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Hyperhidrose, symptom . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Smith CC, Pariser D. Primary focal hyperhidrosis. UpToDate, last updated Oct 11, 2018. www.uptodate.com
- Walling HW. Clinical differentiation of primary from secondary hyperhidrosis. J Am Acad Dermatol. 2011;64(4):690–695. PMID: 21334095 PubMed
- Baumgartner FJ. Hyperhidrosis. BestPractice, last updated July 04, 2014.
- Swartling C, Brismar K, Aquilonius SM, et al. Hyperhidros - det "tysta" handikappet. Lakartidningen. 2011;108(47):2428-32. PubMed
- Shargall Y, Spratt E, Zeldin RA. Hyperhidrosis: what is it and why does it occur? Thorac Surg Clin. 2008;18:125-132. PubMed
- Ricchetti-Masterson K, Symons JM, Aldridge M, et al. Epidemiology of hyperhidrosis in 2 population-based health care databases. J Am Acad Dermatol 2018; 78:358. PubMed
- Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg 2002; 35:382. PubMed
- McConaghy JR, Fosselman D. Hyperhidrosis: Management Options. Am Fam Physician. 2018;97(11):729-734. PMID: 30215934 PubMed
- Solish N, Wang R, Murray CA. Evaluating the patient presenting with hyperhidrosis. Thorac Surg Clin. 2008;18:133-140. PubMed
- Gee S, Yamauchi PS. Nonsurgical management of hyperhidrosis. Thorac Surg Clin. 2008;18:141-155. PubMed
- Alster TS, Harrison IS. Alternative clinical indications of botulinum toxin. Am J Clin Dermatol. 2020;21:855–880. PMID: 32651806 PubMed
- Obed D, Salim M, Bingoel AS, Hofmann TR, Vogt PM, Krezdorn N. Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperhidrosis. Aesthetic Plast Surg. 2021;45(4):1783-1791. PMID: 33619611 PubMed
- Swartlin C, Brismar K, Aquilonius SM et al. Hyperhidros – det »tysta« handikappet. Lakartidningen 2011; 108: 2428-32. pmid:22468383 PubMed
- Lupin M, Hong HC, OʼShaughnessy KF. Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device. Dermatol Surg 2014; 40:805. PubMed
- Glaser DA, Galperin TA. Local procedural approaches for axillary hyperhidrosis. Dermatol Clin 2014; 32:533. PubMed
- Gee S, Yamauchi PS. Nonsurgical management of hyperhidrosis. Thorac Surg Clin. 2008;18:141-155. PubMed
- Wechter T, Feldman SR, Taylor SL. The Treatment of Primary Focal Hyperhidrosis. Skin Therapy Lett. 2019;24(1):1-7. PubMed
- Bechara FG, Sand M, Tomi NS, et al. Repeat liposuction-curettage treatment of axillary hyperhidrosis is safe and effective. Br J Dermatol. 2007;157:739-743. PubMed
- Bechara FG, Altmeyer P, Sand M, et al. Surgical treatment of axillary hyperhidrosis. Br J Dermatol. 2007;156:398-399. PubMed
- Atkinson JL, Fode-Thomas NC, Fealey RD, et al. Endoscopic transthoracic limited sympathotomy for palmar-plantar hyperhidrosis: outcomes and complications during a 10-year period. Mayo Clin Proc 2011; 86:721. PubMed
- Kouris A, Armyra K, Stefanaki C, et al. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with Botulinum Toxin Type A: A case series. Pediatr Dermatol 2014. DOI: 10.1111/pde.12480 DOI
- Deebaj R, Emtestam L, Lundeberg L, et al. Hög nöjdhet med botulinumtoxin vid palmar hyperhidros. Läkartidningen.se 2015-01-22.
- Baumgartner FJ, Bertin S, Konecny J. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis. Ann Vasc Surg. 2009;23:1-7. PubMed